1. Home
  2. JGH vs AXGN Comparison

JGH vs AXGN Comparison

Compare JGH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Global High Income Fund of Beneficial Interest

JGH

Nuveen Global High Income Fund of Beneficial Interest

HOLD

Current Price

$12.54

Market Cap

292.3M

Sector

Finance

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$33.33

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JGH
AXGN
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.3M
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JGH
AXGN
Price
$12.54
$33.33
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$33.67
AVG Volume (30 Days)
73.9K
901.3K
Earning Date
01-01-0001
10-29-2025
Dividend Yield
9.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$214,709,000.00
Revenue This Year
N/A
$21.60
Revenue Next Year
N/A
$15.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.72
52 Week Low
$10.36
$9.22
52 Week High
$12.85
$34.24

Technical Indicators

Market Signals
Indicator
JGH
AXGN
Relative Strength Index (RSI) 50.61 69.70
Support Level $12.39 $32.03
Resistance Level $12.61 $33.30
Average True Range (ATR) 0.07 1.44
MACD 0.03 -0.07
Stochastic Oscillator 70.82 91.74

Price Performance

Historical Comparison
JGH
AXGN

About JGH Nuveen Global High Income Fund of Beneficial Interest

Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: